Skip to primary navigation Skip to main content
Amylin Exploring Possible Sale
Posted on April 23, 2012 at 18:54 PM EDT

Reuters reported that Amylin Pharmaceuticals Inc. (Nasdaq: AMLN) retained the services of Credit Suisse and Goldman Sachs to explore the possible sale of the company sending the stock price soaring $3.14 to close at $26.06.



Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here